The DOI matches its Crossref record; 822 of the 822 references it cites were found in a registry or an index.
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Abstract
Aim: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. Structure: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current American and European guidelines now recommend the use of noncontrast CT‐calcium scoring as a complementary imaging diagnostic test to differentiate between “true‐severe” AS from nonsevere AS in these patients with moderate versus severe DG. 3 , 4”
From Grading of Aortic Valve Calcification Severity and Risk Stratification in Aortic Stenosis (2024) · cites this paper as [3]
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008232 · Cited by 7,205
Self-citationRudski, L., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.010 · Cited by 7,080
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 5,086
Research works printed but not linked: 8
- Cardoso, LF, Grinberg, M, Pomerantzeff, PMA, et al. Comparison of open commissurotomy and balloon valvuloplasty in mitral stenosis: a five-year follow-up. Arq Bras Cardiol. 2004;83:248–52.
- 10.1161/CIRCULATIONAHA.111.072256 · DOI
- 10.1056/NEJMoa1300615 · DOI · Paper page
- 10.1016/j.jcin.2019.03.003 · DOI
- 10.1016/j.athoracsur.2015.04.062 · DOI
- 10.1001/archinte.1994.00420200086009 · DOI
- Taylor, J. The first ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32:3055–6.
- Tumelero, RT, Duda, NT, Tognon, AP, et al. Percutaneous balloon aortic valvuloplasty in a pregnant adolescent. Arq Bras Cardiol. 2004;82:98–101.
Cited by
Sorted by citations
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., Hert, S. G. D., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,287
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation
Hahn, R. T., Makkar, R. R., Thourani, V. H., Makar, M. M., Sharma, R. P., Haeffele, C. L., Davidson, C. J., Narang, A., O'Neill, B. P., Lee, J. D., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2401918 · Cited by 410
Self-citationDreyfus, J., Audureau, É., Bohbot, Y., Coisne, A., Badie, Y. L., Bouchery, M., Flagiello, M., Bazire, B., Eggenspieler, F., Viau, F., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab679 · Cited by 380
Jørgensen, T. H., Thyregod, H. G. H., Ihlemann, N., Nissen, H., Pétursson, P., Kjeldsen, B. J., Steinbrüchel, D. A., Olsen, P. S., & Søndergaard, L. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab375 · Cited by 293
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2115961 · Cited by 269
Self-citation
Metadata
- Authors
- Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., O’Gara, P. T., Rigolin, V. H., Sundt, T. M., Thompson, A., & Toly, C.
- Affiliations
- American College of Cardiology (US)
- ORCID
- Venue
- Circulation
- Published
- 2021-02-02
- Volume
- 143
- Issue
- 5
- Pages
- 450-500
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3110765623
- Cited by
- 2,449
- References
- 821
- Citations by year
- 2026: 189 · 2025: 482 · 2024: 564 · 2023: 514 · 2022: 435 · 2021: 256
- FWCI
- 187.04
- Type
- journal article
- Language
- en
- Update notices
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- valvular heart disease, diagnosis, transcatheter valve therapy, medical therapy, intervention timing
- MeSH terms
- American Heart Association, Cardiology, Heart Valve Diseases, Humans, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review